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doi:10.1016/j.ejvs.2009.08.001Abstract Background: There is considerable controversy regarding the optimal management
of patients undergoing cardiac surgery who are found to have an asymptomatic, unilateral
carotid artery stenosis. Prior to 2004, the policy of this Unit was to perform a synchronous
cardiac and carotid revascularisation. After January 2004, the policy was changed and patients
underwent their cardiac procedure without carotid revascularisation. The aim of this study was
to audit the incidence of stroke in the peri-operative period following this change in practice.
Methods: Five-year audit of the 30-day risk of stroke after 61 consecutive open cardiac proce-
dures in patients with unilateral, asymptomatic 70e99% (NASCET) stenoses who did not
undergo prophylactic carotid endarterectomy.
Results: 61 cardiac procedures; coronary artery bypass grafting (CABG)Z 44, valve replace-
mentZ 6, CABG þ valve replacementZ 9, CABG þ repair of left ventricular aneurysmZ 2
were undertaken and the 30-day outcomes audited. There were three deaths (4.9%), all due
to myocardial infarction. No strokes occurred in any patient in the 30-day post-operative
period.
Conclusion: These results challenge the opinion that the presence of a unilateral, asymptom-
atic carotid stenosis in patients undergoing open cardiac surgery is associated with an
increased risk of peri-operative stroke, sufficient to warrant routine prophylactic carotid re-
vascularisation.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.116 2523252; fax: þ44 116
.nhs.uk (A.R. Naylor).
ty for Vascular Surgery. PublisheIntroduction
There remains considerable controversy regarding the
optimal management of patients undergoing open cardiac
surgery who are found to have a unilateral, asymptomatic
carotid stenosis.1 Current practices range from performingd by Elsevier Ltd. All rights reserved.
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(isolated CABG), to synchronous/staged carotid and coro-
nary revascularisations using either carotid endarterectomy
(CEA) or carotid artery stenting (CAS).
Prior to 2004, the policy in Leicester was to offer
prophylactic CEA (as a synchronous procedure) to patients
undergoing cardiac surgery who presented with either
symptomatic or asymptomatic 70e99% (NASCET) stenoses
of the internal carotid artery, irrespective of whether the
disease were unilateral or bilateral. However, following the
publication of a series of systematic reviews in 2002 and
2003,2e4 this policy was revised and patients found to have
a unilateral asymptomatic carotid stenosis underwent their
cardiac procedure without prophylactic CEA.
Five years after the revised policy was introduced, an
audit was undertaken to determine the incidence of stroke
in the peri-operative period in these 61 patients.
Materials and Methods
Patients undergoing open heart surgery in the Cardiac
Surgery Unit at the Leicester Glenfield Hospital undergo
Duplex ultrasound screening for carotid artery disease if
they present with; (i) significant left mainstem coronary
artery disease, (ii) a carotid bruit or (iii) a history of tran-
sient ischaemic attack (TIA) or stroke. Prior to January
2004, all cardiac surgery patients found to have a unilateral
or bilateral 70e99% stenosis (measured using the NASCET
measurement method, ie equivalent to an 85e99% ECST
stenosis) underwent a synchronous CEA and cardiac
procedure. Following a policy change in January 2004,
patients with an asymptomatic unilateral carotid stenosis
did not undergo a prophylactic CEA.
All 61 patients underwent either coronary artery bypass
grafting (CABG), valve replacement, or a combination of
CABG and either valve replacement or left ventricular
aneurysm repair. No cardiac surgery procedures were per-
formed off-bypass and no cardiac surgery patient with
a neurologically asymptomatic, unilateral carotid stenosis
underwent prophylactic carotid revascularisation during
this five-year period.
All survivors were reviewed by the referring cardiologists
and/or cardiac surgeons four to six weeks post-operatively
as part of an agreed audit of outcome. In January 2009 (five
years after introduction of the policy change), a retro-
spective case-note review was undertaken to determine
whether the performance of cardiac surgery without
prophylactic CEA was associated with an increased risk of
procedural stroke. The Leicestershire, Northamptonshire
and Rutland Research Ethics Committee advised that this
study did not fall under the remit of the NHS Research
Ethics Committee as it was audit/service evaluation.
Results
Between 1st January 2004 and 31st December 2009, 61
consecutive patients undergoing cardiac surgery were
found to have unilateral, asymptomatic 70e99% carotid
stenoses; 34 (56%) also had a contralateral 50e69%
asymptomatic carotid stenosis. The majority of patients
underwent isolated CAGB (nZ 44), six underwent isolatedvalve replacement (aortic valve replacement (AVR)Z 4,
mitral valve replacement (MVR)Z 1, AVRþMVRZ 1), nine
underwent CABG plus valve replacement (AVRZ 4,
MVRZ 5), while two underwent CABG plus repair of a left
ventricular aneurysm.
Three patients (4.9%) died within 30-days of surgery, all
as a consequence of myocardial infarction. Two had
undergone isolated CABG, while one had undergone CABG
plus valve replacement. None of the 61 patients in this
series suffered a stroke in the peri-operative period.
For the purposes of comparison, the overall mortality
rate was 1.6% following 2694 isolated CABG procedures (44/
2694) performed during the same time period as this audit
was undertaken, 4.7% following valve replacement surgery
(74/1565), 7.8% following CABGþ valve replacement
surgery (9/116) and 9.2% following CABGþ ‘other’ proce-
dures (12/131).
Discussion
Despite the fact that almost four decades have elapsed
since Victor Bernhard first questioned whether patients
with coexistent carotid and cardiac disease should undergo
staged or synchronous carotid/coronary revascularisation,5
there is still considerable controversy and no overall
consensus regarding what constitutes optimal manage-
ment.1 The aetiology of post-CABG stroke is multifactorial
and while carotid disease is certainly an important risk
factor,2 the single most common cause is probably thrombo-
embolism from the aortic arch.6 As a consequence of
increasing awareness regarding the role of aortic pathology
in post-CABG stroke, a number of vascular centres around
the world have begun to question the value of prophylactic
carotid endarterectomy (CEA) or carotid artery stenting
(CAS) in the management of patients with combined carotid
and cardiac disease.
Evidence suggests that cardiac surgery patients with
a symptomatic carotid stenosis do face a significantly
increased risk of procedural stroke.7 In this situation,
staged or synchronous carotid and cardiac revascularisation
can be justified. However, the management of cardiac
surgery patients with unilateral or bilateral asymptomatic
carotid disease remains enduringly controversial.1 For
some, the available evidence is compelling enough to
recommend staged CASþ CABG in all asymptomatic
patients with unilateral carotid disease,8 while for others,
the same evidence militates against any form of prophy-
lactic carotid intervention.9
Prior to 2004, the policy in the Leicester Cardiac and
Vascular Surgery Units was to screen all cardiac surgery
patients for carotid disease if they presented with; (i) left
mainstem disease, (ii) a history of TIA or stroke and (iii)
a carotid bruit. Patients with a 70e99% stenosis (NASCET)
then underwent synchronous carotid and coronary revas-
cularisation, irrespective of neurological symptom status
(asymptomatic/symptomatic) or extent of disease (unilat-
eral/bilateral). However, following the publication of
a series of themed systematic reviews,2e4 a review of
practice was undertaken. This was because the available
evidence suggested that; (i) the risk of stroke in cardiac
surgery patients with unilateral asymptomatic carotid
disease appeared to be low (3e5%),2 (ii) that 85% of stroke
558 D. Baiou et al.sufferers had no evidence of ipsilateral, significant carotid
disease,2 while (iii) MRI studies suggested that up to 80% of
post-CABG stroke patients had areas of infarction that were
incompatible with having been caused primarily by carotid
disease.10
After a review of practice, it was decided to continue
offering prophylactic CEA to all cardiac patients with
a previously symptomatic 70e99% carotid stenosis and also
to patients with bilateral, asymptomatic 70e99% stenoses
(contralateral occlusion). However, cardiac surgery
patients with a unilateral 70e99% stenosis did not, there-
after, undergo prophylactic CEA.
In the five years since the policy was revised, 61 patients
with a known asymptomatic 70e99% carotid stenosis
underwent cardiac surgery without synchronous carotid
revascularisation. The authors accept that an otherwise
unknown number of unscreened patients will also have
undergone cardiac surgery in the presence of significant
carotid disease without prophylactic carotid revascularisa-
tion. Although three (4.9%) died (all following acute
myocardial infarction), none of the 61 patients suffered
a stroke in the first 30 days after cardiac surgery. This
finding corroborates a 2005 audit from Manchester UK,9
where a similar policy of not offering prophylactic CEA to
cardiac surgery patients with unilateral or bilateral
asymptomatic carotid disease had been implemented. In
Ghosh’s study, 50 neurologically asymptomatic patients
underwent CABG with no strokes being observed in the first
30 days.
There are few other directly comparable studies as it is;
(i) often unclear from reading the constituent papers
whether the unit selected some patients for prophylactic
CEA but not in others and (ii) few studies provided separate
outcome data for asymptomatic patients with unilateral
and bilateral disease. However, several other studies are
worthy of mention. Schwartz11 observed that in 67 CABG
patients with a unilateral 50e99% asymptomatic carotid
stenosis, the risk of stroke in patients undergoing CABG
alone was only 1.5%. In 25 CABG patients with a unilateral
80e99% stenosis, the stroke risk was only 4%. Similarly,
Nakamura reported a zero percent risk of stroke in 29
patients with significant, asymptomatic carotid disease
(but no evidence of impaired cerebral vascular reserve)
who then underwent isolated CABG.12 Finally, Manabe
reported no peri-operative strokes in 41 cardiac surgery
patients with unilateral, asymptomatic carotid stenoses
(50e69% (nZ 34), 70e99% (nZ 7)) who underwent their
cardiac procedures without concomitant carotid
revascularisation.13
These studies (including our own) involve relatively
small patient numbers, but they do challenge the hypo-
thesis that performing a staged or synchronous cardiac and
carotid revascularisation (by either CEA or CAS) will
significantly reduce the risk of post-CABG stroke in patients
with asymptomatic, unilateral carotid disease. Unfortu-
nately, few constituent studies from the systematic reviews
of staged/synchronous CEAþ CABG have included data of
sufficient quality to permit comparison with meta-analyses
of 30-day stroke risks in asymptomatic patients with
unilateral, carotid artery disease. Better quality data is,
however, emerging from some of the CAS centres. In van
der Heyden’s series of 356 neurologically asymptomaticpatients undergoing CAS prior to their cardiac surgery
procedure,8 334 (94%) had unilateral carotid disease.
Overall, the 30-day death/stroke rate following staged
CASþ CABG was 6.7%. The authors thereafter concluded
that the morbidity/mortality rate observed in their study
was sufficiently low to justify staged CASþ CABG in
patients with unilateral, asymptomatic carotid disease. Our
study and those others cited above, would seem to question
whether such a statement can be supported.
In conclusion, this single centre study is too small to
provide conclusive evidence that the presence of a unilat-
eral, asymptomatic carotid stenosis is not associated with
an increased risk of stroke following cardiac surgery if
prophylactic CEA is not performed. It does, however,
challenge prevailing opinion that prophylactic CEA or CAS
can be expected to significantly reduce the risk of stroke in
this category of patient. In the absence of randomised
trials, the authors urge colleagues who have adopted
a similar policy of not offering prophylactic carotid revas-
cularisation to cardiac surgery patients with asymptomatic,
unilateral carotid stenoses to publish their experience and
so further inform the debate.Conflict of Interest/Funding
None.
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